Pediococcus acidilactici derived antimicrobial hexapeptide and preparation method thereof

US10487112B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10487112-B2
Application numberUS-201615746596-A
CountryUS
Kind codeB2
Filing dateSep 8, 2016
Priority dateAug 25, 2016
Publication dateNov 26, 2019
Grant dateNov 26, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A Pediococcus acidilactici derived antimicrobial hexapeptide and a preparation method thereof are disclosed herein. The antimicrobial peptide ENGEEE (SEQ ID NO: 1) is reported for the first time. Antimicrobial peptide lactein R16 has good pH stability and thermal stability, has an effect on inhibiting Escherichia coli, Listeria monocytogenes and Staphylococcus aureus and is capable of effectively reducing the amount of the Escherichia coli in soybean meal. Secondly, the antimicrobial peptide lactein R16 has a certain effect on proliferating Saccharomyces cerevisiae and Lactobacillus plantarum and has certain capability of clearing hydrogen peroxide, hydroxyl radicals, DPPH radicals and superoxide anions. The antimicrobial peptide lactein R16 can be used for biological control and can be used as a feed additive to play important roles in substituting antibiotics and solving the feed safety problem.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising an antimicrobial peptide consisting of the amino acid sequence of SEQ ID NO: 1, and a soybean meal. 2. The composition of claim 1 , further comprising Escherichia coli. 3. A method of inhibiting bacterial infection in a subject, comprising administering the composition of claim 1 to the subject in need thereof. 4. The method of claim 3 , wherein the bacterial infection is selected from the group consisting of Escherichia coli, Listeria monocytogenes and Staphylococcus aureus.

Assignees

Inventors

Classifications

  • Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof · CPC title

  • N-acyl derivatives · CPC title

  • Microorganisms; Enzymes; {Antibiotics} · CPC title

  • Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation · CPC title

  • Polymeric derivatives, e.g. peptides or proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10487112B2 cover?
A Pediococcus acidilactici derived antimicrobial hexapeptide and a preparation method thereof are disclosed herein. The antimicrobial peptide ENGEEE (SEQ ID NO: 1) is reported for the first time. Antimicrobial peptide lactein R16 has good pH stability and thermal stability, has an effect on inhibiting Escherichia coli, Listeria monocytogenes and Staphylococcus aureus and is capable of effective…
Who is the assignee on this patent?
Univ Jiangnan
What technology area does this patent fall under?
Primary CPC classification C07K7/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).